Metastatic lung cancer: what Europe's new policy report calls for
More people in Europe are living for years with metastatic lung cancer, but care, communication and legal protection have not kept pace. The European Cancer Organisation's new Policy Action Report sets out what needs to change, with a contribution from Lung Cancer Europe President Debra Montague.
PFAS restrictions and medicines: what is the EU proposing, and how it might affect lung cancer treatment
The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.
How the EU’s Next Long-Term Budget Will Affect People Living with Lung Cancer
Lung Cancer Europe President Debra Montague is among more than 490 healthcare experts, researchers, academics, and patient advocates calling for a dedicated, ring-fenced health budget in the EU’s next long-term budget. Here is what the MFF 2028-2034 negotiations mean for people living with lung cancer across Europe.